Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07062887 · ClinicalTrials.gov registry record · NA
Digital Mindfulness for Young Adults With Type 1 Diabetes
A NA study of Type 1 Diabetes (T1D) and Diabetes Secondary to Pancreatitis, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07062887: Recruiting NA study of Type 1 Diabetes (T1D) and Diabetes Secondary to Pancreatitis, sponsored by Yale University.
NCT07062887 is a NA study of Type 1 Diabetes (T1D) and Diabetes Secondary to Pancreatitis that is actively recruiting participants, run by Yale University. The registered enrollment target is 10 participants, below the 180-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07062887, a NA study of Type 1 Diabetes (T1D) and Diabetes Secondary to Pancreatitis, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to test a mindfulness app called Calm Health among young adults with type 1 diabetes or other absolute insulin deficiency diabetes. Mindfulness is the practice of being aware of your thoughts and feelings in the moment without judgment or negative reaction. All participants will receive mindfulness guidance and personalized feedback about the relationship among your mindfulness, blood sugar, stress, and sleep.
Primary Outcome
Minutes of usage per week
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness app
Study Locations (1)
Connecticut
- Yale University School of Medicine - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-02-04 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT07062887 shows while recruiting
NCT07062887 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 180-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Type 1 Diabetes (T1D) appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness app is the first listed.
NCT07062887 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT07062887 about?
NCT07062887 is a clinical study titled "Digital Mindfulness for Young Adults With Type 1 Diabetes". The purpose of this research study is to test a mindfulness app called Calm Health among young adults with type 1 diabetes or other absolute insulin deficiency diabetes. Mindfulness is the practice of being aware of your thoughts and feelings in the moment without judgment or negative reaction. All ...
What is the current status of trial NCT07062887?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-02-04. Estimated completion is 2026-09.
What conditions does trial NCT07062887 study?
This clinical trial studies the following conditions: Type 1 Diabetes (T1D), Diabetes Secondary to Pancreatitis.
What interventions are being tested in trial NCT07062887?
The interventions under investigation include: Mindfulness app (BEHAVIORAL).
Who is sponsoring clinical trial NCT07062887?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07062887 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes (T1D)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07062887's enrollment target sits among peer trials
10 18th of 17 the lowest of 17 other Type 1 Diabetes (T1D) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes (T1D) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
RECRUITING · NA
-
Circadian Mechanisms, Glucose, and CV Risks in T1D
RECRUITING · NA
-
Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes
RECRUITING · NA
-
Automated Insulin for Management of Intrapartum Glycemia
RECRUITING · NA
-
Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery
RECRUITING · NA
-
Type 1 Diabetes and Obstructive Sleep Apnea
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI